NCT00019968
- Conditions
- Muscle Neoplasms, Muscular Diseases, Musculoskeletal Diseases, +12 more
- Locations
-
Not specified
Clinical trial condition
Stage III Adult Soft Tissue Sarcoma
Explore clinical trials studying Stage III Adult Soft Tissue Sarcoma. Study availability and eligibility vary by location and protocol.
25 public trials
0 recruiting studies
Stage III Adult Soft Tissue Sarcoma trial results
NCT01462630
- Conditions
- Adult Angiosarcoma, Hemangiosarcoma, Neoplasms, +7 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- University of Michigan Ann Arbor, Michigan, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
- Hollings Cancer Center Medical University of South Carolina Charleston, South Carolina, United States
NCT00346164
- Conditions
- Adult Alveolar Soft-part Sarcoma, Adult Angiosarcoma, Adult Epithelioid Sarcoma, +56 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Phoenix Childrens Hospital Phoenix, Arizona, United States
- University of Arizona Health Sciences Center Tucson, Arizona, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
Completed
Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma
NCT02048722
- Conditions
- Adult Angiosarcoma, Hemangiosarcoma, Neoplasms, +7 more
- Locations
-
- Sarcoma Oncology Center Santa Monica, California, United States
- Mayo Clinic in Florida Jacksonville, Florida, United States
- Northwestern University Chicago, Illinois, United States
- University of Iowa Iowa City, Iowa, United States
NCT01446809
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +4 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT02180698
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +3 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
A Phase II Study of Tivozanib in Patients With Metastatic and Non-resectable Soft Tissue Sarcomas
NCT01782313
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective and Soft Tissue, +4 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- University of Iowa Iowa City, Iowa, United States
- Mayo Clinic Rochester, Minnesota, United States
- Washington University St Louis, Missouri, United States
NCT01154452
- Conditions
- Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor, +85 more
- Locations
-
- Memorial Sloan-Kettering Cancer Center New York, United States
NCT01553539
- Conditions
- Bone Cancer, Bone Diseases, Bone Neoplasms, +20 more
- Locations
-
- Wake Forest University Health Sciences Winston-Salem, North Carolina, United States
Completed
AZD0530 in Treating Patients With Recurrent Locally Advanced or Metastatic Soft Tissue Sarcoma
NCT00659360
- Conditions
- Adult Fibrosarcoma, Adult Leiomyosarcoma, Adult Liposarcoma, +41 more
- Locations
-
- Fox Chase Cancer Center Rockledge, Pennsylvania, United States
- Cross Cancer Institute Edmonton, Alberta, Canada
- University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada
- Montreal General Hospital Montreal, Quebec, Canada